Eplus SEC Filings

ePlus inc. (PLUS) reported strong quarterly results for the three months ended September 30, 2025. Net sales reached $608.8 million, up from $493.4 million a year ago, with gross profit of $162.1 million and operating income of $48.8 million. Net earnings from continuing operations were $38.2 million, or $1.45 per diluted share; total diluted EPS was $1.32.

Growth was broad-based: Product revenue was $485.0 million, Professional Services $76.3 million, and Managed Services $47.4 million. Gross margin improved to 26.6% from 25.8%, driven largely by higher product margins and mix. Other income rose to $5.2 million on higher interest income and FX gains.

Following the June 30, 2025 sale of its domestic financing business, ePlus is now a pure-play technology solutions provider. The transaction delivered net cash proceeds of $156.7 million and established a $13.5 million contingent consideration asset. Cash and equivalents were $402.2 million at quarter end. Operating cash flow from continuing operations was an outflow of $137.6 million, reflecting working capital movements.

ePlus inc. (PLUS) filed an 8-K announcing quarterly results and a cash dividend. The company reported that it issued a press release covering results for the three and six months ended September 30, 2025.

The Board declared a quarterly cash dividend of $0.25 per common share, payable on December 17, 2025, to shareholders of record as of the close of business on November 25, 2025.

The referenced press release (Exhibit 99.1) includes additional details on second-quarter and first-half performance, while the dividend sets clear record and payment dates for holders.

ePlus Inc. (PLUS) reported an initial statement of beneficial ownership on Form 3 for its General Counsel, Erica S. Stoecker. The filing lists 6,520 shares of common stock beneficially owned with direct ownership.

The date of the event requiring the statement was 10/20/2025. No derivative securities were reported in the filing.

ePlus Inc. (PLUS) reported an insider equity grant. A director acquired 1,478 shares of common stock on 10/01/2025 as a restricted stock award under the company’s 2024 Non-Employee Director Long Term Incentive Plan. The grant price was $0.

The restricted shares are subject to a restriction period ending on the first anniversary of the grant, with potential lapse or forfeiture under the plan’s terms. After the transaction, the director beneficially owns 13,838 shares, held directly.

Ira A. Hunt, a Director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of common stock on 10/01/2025 under the company's 2024 Non-Employee Director Long Term Incentive Plan. The award was granted at a reported price of $0 and is subject to a restriction period that ends on the first anniversary of the grant, during which the shares may vest early under certain plan conditions or be forfeited.

Following the grant, Mr. Hunt beneficially owned 27,806 shares. The Form 4 was signed by the reporting person on 10/03/2025. The filing discloses the grant terms and the existence of the restriction period but contains no additional financial metrics, transaction consideration beyond the $0 reported price, or changes to prior holdings other than the post-grant ownership total.

John E. Callies, a director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of the company's common stock on 10/01/2025 under the 2024 Non-Employee Director Long Term Incentive Plan. The award was granted at no cash price ($0) and is subject to a restriction period that ends on the first anniversary of the grant, during which the shares may vest or be forfeited under the plan's terms. Following the grant, Mr. Callies beneficially owns 21,988 shares.

The transaction was reported on a Form 4 and signed by the reporting person. The grant increases the director's ownership stake while imposing a one-year restriction period designed to align his interests with shareholders during that term.

Bruce M. Bowen, a director of ePlus Inc. (PLUS), reported several transactions dated 10/01/2025 on Form 4. He received a grant of 1,478 restricted shares under the company’s 2024 Non-Employee Director Long Term Incentive Plan that vest after a one-year restriction period. On the same date he transferred 2,687 shares from his personal account to the Bruce Montague Bowen Trust for no consideration; he is the trustee and sole beneficiary and remains the beneficial owner of those shares. He was also issued 300 shares by election in lieu of cash compensation. The Form lists various post-transaction holdings, including 4,165 shares shown as direct ownership and 15,213 shares held indirectly by the trust.

ePlus Inc. (PLUS) reported a Form 4 for Director Renee Bergeron. On 10/01/2025, she acquired 1,478 shares of common stock at $0 as a restricted stock award, increasing her directly held shares to 5,772.

The award was granted under the Company’s 2024 Non-Employee Director Long Term Incentive Plan and is subject to a Restriction Period ending on the first anniversary of the grant. Under certain circumstances described in the plan, restrictions may lapse or the shares may be forfeited and transferred back to the Company.

Melissa J. Ballenger, a director of EPLUS INC (PLUS), was granted 1,478 shares of restricted common stock on 10/01/2025 under the company’s 2024 Non-Employee Director Long Term Incentive Plan. The award carries a one‑year restriction period that begins on the grant date, after which restrictions may lapse or, under certain circumstances described in the plan, the shares may be forfeited and returned to the company. Following this grant, Ms. Ballenger beneficially owns 2,525 shares. The reported acquisition price is $0, and the Form 4 was signed on 10/03/2025.